Company Profile

  1. You are here:    Home
  2. Search Databases
  3. Search Company Registry
  4. Company Profile

Glaukos Corporation
Profile last edited on: 12/2/2023      CAGE: 8QAP5      UEI: M77LMBPAZLL9

Business Identifier: Medical devices and therapies to treat glaucoma; iStent
Year Founded
1998
First Award
2002
Latest Award
2005
Program Status
Inactive
Popularity Index

Edit Company Profile

Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
  Explanation Edit

Location Information

26051 Merit Circle Suite 103
Laguna Hills, CA 92653
   (949) 367-9600
   contact@glaukos.com
   www.glaukos.com
Location: Single
Congr. District: 45
County: Orange

Public Profile

Glaukos Corporation is the founder of MIGS - Micro Invasive Glaucoma Surgery- a new ophthalmic device market class that was spearheaded by the company’s 2012 U.S. FDA approval of the iStent implant - the smallest medical device ever implanted into humans. The company is actively developing and conducting clinical evaluations in FDA approved IDE trials of two new generations of the iStent device to provide additional safe, effective and sustained procedures to treat glaucoma.

Extent of SBIR involvement

User Avatar
Phase I Awards
2
Phase II Awards
0
Conversion Rate
0.00%
Phase I Dollars
$200,000
Phase II Dollars
$0
Total Awarded
$200,000

Synopsis: Awardee Business Condition

Employee Range
500+
Revenue Range
Over 50M
VC funded?
Yes
Public/Private
Publicly Traded
Stock Info
NYSE : GKOS
IP Holdings
150-249

Awards Distribution by Agency

Most Recent SBIR Projects
Year Phase Agency Total Amount
2005 1 NIH $100,000
Project Title: Development of a micropump for the glaucomatous eye
2002 1 NIH $100,000
Project Title: Trabecular Bypass Stent and Applicator

Key People / Management

  Thomas W Burns -- President and CEO, Director

  Olav B Bergheim -- Founder

  Chris Calcaterra -- Chief Commercial Officer

  David Haffner -- VP, Product Development

  David S Haffner

  Richard Harrison -- Chief Financial Officer

  Hal Heitzmann -- VP, Applied Research

  Richard A Hill -- Founder and Member of Scientific Advisory Board

  Jeff Wells -- Sr. VP, Clinical, Regulatory and Quality Affair

Company News

Sep 27 2012
Looking for the 'Next Big Thing'? Ranking the Top 50 Start-Ups
Sep 27 2012
Biotech stars make WSJ's list of top startups as healthcare lags